Table 1 Characteristics of the patients and tumors included in the microarray analysis.

1

M

60

W

Yes

< 5^a

Microvascular

1

Right lobe

T1N0M0

2

M

56

B

Yes

< 5

Microvascular

1

Right lobe

T1N0M0

3

F

69

H

Yes

< 5

Microvascular

2

Right lobe

T2N0M0

4

M

58

W

Yes

< 5

Microvascular

2

Right lobe

T2N0M0

5

M

56

W

Yes

< 5

Microvascular

2

Right lobe

T2N0M0

6

F

62

W

Yes

> 5^b

Microvascular

1

Left lobe

T3N0M0

7

M

61

W

Yes

> 5

Microvascular

2

Right lobe

T3N0M0

8

F

60

W

Yes

> 5

Microvascular

3

Bilobar

T3N0M0

9

M

54

H

Yes

> 5

Macrovascular

> 3

Bilobar

T4N0M0

Patients 1–5: Pool 1 Early HCV-HCC

Patients 6–9: Pool 2 Advanced HCV-HCC

HCV-HCC individual samples^c

Patient

Sex

Age, y

Race

Tumor size, cm

Vascular invasion^d

Tumor number

Lobar distribution

Enlisted stage

Explanted stage

10

M

47

B

< 5

Microvascular

1

Right lobe

T2N0M0

T2N0M0

11

M

44

W

< 5

Microvascular

1

Right lobe

T1N0M0

T1N0M0

12

M

44

B

< 5

Microvascular

1

Right lobe

T2N0M0

T2N0M0

13

M

49

H

< 5

Microvascular

1

Right lobe

T2N0M0

T2N0M0

14

F

54

W

< 5

Microvascular

2

Right lobe

T2N0M0

T2N0M0

15^e

M

52

W

> 5

Microvascular

2

Bilobar

T2N0M0

T3N0M0

16^e

M

56

W

> 5

Macrovascular

2

Bilobar

T2N0M0

T4N0M0

17^e

M

66

W

> 5

Microvascular

1

Right lobe

T2N0M0

T3N0M0

18^e

M

68

W

> 5

Microvascular

1

Right lobe

T2N0M0

T3N0M0

19^e

M

58

H

> 5

Microvascular

2

Bilobar

T3N0M0

T4N0M0

20^e

M

56

W

> 5

Microvascular

2

Bilobar

T2N0M0

T4N0M0

21^e

M

58

W

> 5

Microvascular

3

Right lobe

T2N0M0

T4N0M0

22

M

66

W

< 5

Microvascular

1

Right lobe

T2N0M0

T2N0M0

23

M

41

W

> 5

Microvascular

2

Right lobe

T3N0M0

T3N0M0